Bodilisant - A novel fluorescent, highly affine histamine H3 receptor ligand

ACS Medicinal Chemistry Letters

Volumn 4, Issue 2, 2013, Pages 269-273

  Tomasch, Miriam ^a   Schwed, J Stephan ^a   Paulke, Alexander ^a   Stark, Holger ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

BODIPY; displacement; fluorescence confocal laser scanning microscopy; GPCR; H3 receptor; HEK 293 cells; histamine; nonimidazole derivative; pharmacological tool; tissue labeling

Indexed keywords

BODILISANT; CIPROXIFAN; HISTAMINE H3 RECEPTOR; HISTAMINERGIC RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TISSUE; CELL STRAIN HEK293; CONFOCAL LASER MICROSCOPY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; LIGAND BINDING; PRIORITY JOURNAL;

EID: 84873947024     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300383n     Document Type: Article

References (39)

1. Walter, M.; Stark, H. Histamine receptor subtypes: S century of rational drug design Front. Biosci. (Schol. Ed.) 2012, 4, 461-488
2. 3) visualized in the brain of human and non-human primates Brain Res. 1990, 526, 322-327
3. 3 Receptor Antagonists Go to Clinics Biol. Pharm. Bull. 2008, 31, 2163-2181
4. 3 receptors on endocrine cells in the rat gastrointestinal tract Histol. Histopathol. 2008, 23, 789-798
5. Chazot, P. L.; Hann, V.; Wilson, C.; Lees, G.; Thompson, C. L. Immunological identification of the mammalian H3 histamine receptor in the mouse brain NeuroReport 2001, 12, 259-262
6. 3R445/453 isoform specific antibody probe Inflammation Res. 2009, 58 (Suppl. 1) S43-S44
7. Ramos-Vara, J. A. Technical Aspects of Immunohistochemistry Vet. Pathol. 2005, 42, 405-426
8. Middleton, R. J.; Kellam, B. Fluorophore-tagged GPCR ligands Curr. Opin. Chem. Biol. 2005, 9, 517-525
9. Kuder, K. J.; Kiec-Kononowicz, K. Fluorescent GPCR ligands as new tools in pharmacology Curr. Med. Chem. 2008, 21, 2132-2143
10. 3 receptor ligands as pharmacological tools. Front. Syst. Neurosci. 2012, 6 (14), DOI: 10.3389/fnsys.2012.00014.
11. 3 receptor ligands with fluorescent properties Inflammation Res. 2010, 59, S247-S248
12. 3 receptor ligands with nanomolar affinities Bioorg. Med. Chem. Lett. 2006, 16, 1938-1940
13. 3 receptor ligands Chem. Med. Chem. 2007, 2, 708-716
14. Loudet, A.; Burgess, K. BODIPY Dyes and Their Derivatives: Syntheses and Spectroscopic Properties Chem. Rev. 2007, 107, 4891-4932
15. Kálai, T.; Hideg, K. Synthesis of new, BODIPY-based sensors and labels Tetrahedron 2006, 62, 10352-10360
16. Inoue, N.; Suzuki, Y.; Yokoyama, K.; Karube, I. Novel Fluorescent Probe for Analysis of Hydroperoxides Based on Boron Dipyrromethane Fluorophore Biosci., Biotechnol., Biochem. 2009, 73, 1215-1217
17. Dumont, Y.; Gaudreau, P.; Mazzuferi, M.; Langlois, D.; Chabot, J.-G.; Fournier, A.; Simonato, M.; Quirion, R. BODIPYs-conjugated neuropeptide Y ligands: New fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes Br. J. Pharmacol. 2005, 146, 1069-1081
18. Freudenthal, S. J. Fluorophordesign und Fluoreszenzmarkierung: Synthese funktionalisierter BODIPY-Derivate und Markierung von Purinrezeptor-Liganden. Ph.D. Thesis; Rheinische Friedrich-Wilhelms-Universität Bonn: Bonn, Germany, 2002.
19. Briddon, S. J.; Middleton, R. J.; Yates, A. S.; George, M. W.; Kellamb, B.; Hill, S. J. Application of fluorescence correlation spectroscopy to the measurement of agonist binding to a G-protein coupled receptor at the single cell level Faraday Discuss. 2004, 126, 197-207
20. Briddon, S. J.; Middleton, R. J.; Cordeaux, Y.; Flavin, F. M.; Weinstein, J. A.; George, M. W.; Kellam, B.; Hill, S. J. Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 4673-4678
21. Dale, C. L.; Hill, S. J.; Kellam, B. New potent, short-linker BODIPY-630/650 labelled fluorescent adenosine receptor agonists Med. Chem. Comm. 2012, 3, 333-338
22. 2- adrenoceptor agonist Br. J. Pharmacol. 2003, 139, 232-242
23. Tahtaoui, C.; Parrot, I.; Klotz, P.; Guillier, F.; Galzi, J.-L.; Hibert, M.; Ilien, B. Fluorescent Pirenzepine Derivatives as Potential Bitopic Ligands of the Human M1Muscarinic Receptor J. Med. Chem. 2004, 47, 4300-4315
24. Monsma, F. J.; Barton, A. C.; Kang, H. C.; Brassard, D. L.; Haugland, R. P.; Sibley, D. R. Characterization of Novel Fluorescent Ligands with High Affinity for D1 and D2 Dopaminergic Receptors J. Neurochem. 1989, 52, 1641-1644
25. Rose, R. H.; Briddon, S. J.; Hill, S. J. A novel fluorescent histamine H1 receptor antagonist demonstrates the advantage of using fluorescence correlation spectroscopy to study the binding of lipophilic ligands Br. J. Pharmacol. 2012, 165, 1789-1800
26. Xie, S.-X.; Petrache, G.; Schneider, E.; Ye, Q.-Z.; Bernhardt, G.; Seifert, R.; Buschauer, A. Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine Bioorg. Med. Chem. Lett. 2006, 16, 3886-3890
27. τ-methyltransferase: ether derivatives Pharmazie 2005, 60, 97-106
28. 3 receptor ligands Chem. Pharm. Bull. 2010, 58, 1353-1361
29. Williamson, A. About the theory of the formation of ethers Ann. Chem. 1851, 77, 37-49
30. Fery-Forgues, S.; Lavabre, D. Are Fluorescence Quantum Yields So Tricky to Measure? A Demonstration Using Familiar Stationary Products J. Chem. Educ. 1999, 76, 1260-1264
31. Madge, D.; Wong, R.; Seybold, P. G. Fluorescence Quantum Yields and Their Relation to Lifetime of Rhodamine 6G and Fluorescein in Nine Solvents: Improved Absolute Standards for Quantum Yields Photochem. Photobiol. 2002, 75, 327-334
32. 4 receptor ligands Eur. J. Pharmacol. 2011, 654, 200-208
33. Bradford, M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976, 72, 248-254
34. 4 receptors are involved in pruritus Neuroscience 2011, 190, 89-102
35. Von Coburg, Y.; Kottke, T.; Weizel, L.; Ligneau, X.; Stark., H. Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics Bioorg. Med. Chem. Lett. 2009, 19, 538-542
36. Boecker, A.; Sasse, B. C.; Nietert, M.; Stark, H.; Schneider, G. GPCR Targeted Library Design: Novel Dopamine D3 ReceptorLigands Chem. Med. Chem. 2007, 2, 1000-1005
37. 3 receptors: Role of two amino acids in the third transmembrane domain Br. J. Pharmacol. 2000, 131, 1247-1250
38. Haas, H. L.; Sergeeva, O.; Selbach, O. Histamine in the Nervous System Physiol. Rev. 2008, 88, 1183-1241
39. Bonnekoh, B.; Böckelmann, R.; Pommer, A. J.; Malykh, Y.; Phillipsen, L. The CD11a Binding Site of Efalizumab in Psoriatic Skin Tissue as Analyzed by Multi-Epitope Ligand Cartography Robot Technology Skin Pharmacol. Physiol. 2007, 20, 96-111